What's new

RSS
Date Content
31/05/2018 Orphan designation: Rucaparib for the: Treatment of ovarian cancer, 10/10/2012, Positive (updated)
31/05/2018 Human medicines European public assessment report (EPAR): rucaparib, Rubraca, rucaparib, Ovarian Neoplasms, 23/05/2018, Authorised (updated)
31/05/2018 Human medicines European public assessment report (EPAR): palivizumab, Synagis, palivizumab, Respiratory Syncytial Virus Infections, 13/08/1999, 39, Authorised (updated)
31/05/2018 Human medicines European public assessment report (EPAR): silodosin, Silodyx, silodosin, Prostatic Hyperplasia, 29/01/2010, 12, Authorised (updated)
31/05/2018 Committee meeting report: Monthly report on application procedures guidelines and related documents for veterinary medicines: April 2018 (updated)
31/05/2018 Committee for Medicinal Products for Veterinary Use (CVMP): 17-19 April 2018 , European Medicines Agency, London, UK, from 17/04/2018 to 19/04/2018 (updated)
31/05/2018 Minutes: Minutes of the CHMP meeting 19-22 March 2018 (updated)
31/05/2018 Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018 , European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018 (updated)
31/05/2018 Human medicines European public assessment report (EPAR): vildagliptin / metformin, Eucreas, vildagliptin / metformin, Diabetes Mellitus, Type 2, 14/11/2007, 17, Authorised (updated)
30/05/2018 Veterinary medicines European public assessment report (EPAR): grapiprant, Galliprant, grapiprant, 09/01/2018, 1, Authorised (updated)